Announcement from Viva Wine Group’s annual general meeting 2023
The annual general meeting 2023 (the "AGM") of Viva Wine Group AB ("Viva Wine Group" or the "Company") was held today on 16 May 2023 and the following resolutions were passed by the meeting.
Adoption of the income statement and the balance sheet
The AGM resolved to adopt the income statement and the balance sheet in Viva Wine Group and the consolidated income statement and the consolidated balance sheet.
Allocation of profit
The AGM resolved to pay out dividend of SEK 1.55 per share. The record date shall be 19 May 2023. Payment of dividends from Euroclear is expected to take place on 24 May 2023. Dividends to holders of shares amount to a maximum of SEK 137,689,420.
Discharge from liability
The board of directors and the CEO were discharged from liability for the financial year 2022.
Election of the board of directors, auditor and remuneration
The AGM resolved that the board of directors shall comprise five directors and no deputy directors. It was also resolved that the number of auditors shall be one registered audit firm.
It was further resolved that the remuneration to the directors is to be in total SEK 1,850,000 excluding remuneration for committee work (SEK 2,150,000 previous year excluding remuneration for committee work) in accordance with the following:
- SEK 300,000 (SEK 300,000) for each of the non-employed director and SEK 650,000 (SEK 650,000) to the chairman provided that the chair is not an employee.
It was also resolved that remuneration for committee work shall be paid in the following amounts:
- SEK 100,000 to the chairman and SEK 60,000 to the other members of the audit committee.
It was further resolved that remuneration to the auditor shall be paid in accordance with approved invoices.
Anders Moberg, Anne Thorstvedt Sjöberg, John Wistedt, Lars Ljungälv and Mikael Aru were re-elected as directors of the board. It was also resolved to re-elect Anders Moberg as chairman of the board. Helen Fasth Gillstedt had announced that she was not available for re-election.
Ernst & Young Aktiebolag was re-elected as the Company auditor. Ernst & Young Aktiebolag has announced that Andreas Nyberg will continue to act as main responsible auditor.
Adoption of principles for the nomination committee
The AGM resolved to adopt principles for the nomination committee. The principles are unchanged from the annual general meeting 2022.
Authorization for the board to resolve on issuances
The AGM resolved, in accordance with the board of directors' proposal, to authorize the board of directors until the next annual general meeting, on one or more occasions, with or without preferential rights for the shareholders, to issue shares, warrants and/or convertibles, with the right to subscribe for and convert into shares in the Company, respectively, corresponding to a maximum of 20 percent of the Company's share capital after dilution based on the number of shares in the Company at the time of the annual general meeting, to be paid in cash, through set-off or in kind.
The primary purpose of the authorization is for the board of directors to be able to resolve to issue new shares, without preferential rights, in order to raise new capital which will increase the Company's flexibility or in connection with acquisitions or as payment for additional considerations in regards to already finalized acquisitions.
Issuance of new shares, pursuant of the authorization, shall be carried out in accordance with customary terms and conditions under prevailing market conditions.
For detailed terms regarding the resolutions at the AGM as described above, please refer to the notice and the annual report which are available on the Company's website, https://investors.vivagroup.se/
FNCA Sweden AB, is the Company's Certified Adviser on Nasdaq First North Premier Growth Market.
For further information, please contact:
Mikael Sundström, Director Sustainability, Communications & Investor Relations
Mobile: +46 70 943 22 26
Director Sustainability, Communication & Investor Relationsmikael.email@example.com